GENOLUTION, Inc. engages in the research and development of nucleic acid extractors. It operates through the Vitro Diagnostic and RNAi business divisions. The company was founded on February 20, 2006 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company